Today: 26 November 2025
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Netflix Stock Soars to Record Highs Amid Bold Deals and Streaming War Shake-Up

Netflix Stock Today, November 18, 2025: NFLX Rises After 10‑for‑1 Split as Wall Street Recalibrates Targets

Netflix stock (NASDAQ: NFLX) is trading higher today, 18 November 2025, as investors digest the company’s fresh 10‑for‑1 stock split, blockbuster Q3 numbers, options-market fireworks, and new chatter about a possible Warner Bros. Discovery deal. Key takeaways for Netflix stock
18 November 2025
 ·  ·  ·  ·  · 
Palantir (PLTR) Today: Stock Slips as Valuation Debate Heats Up—Fresh Analyst Notes, $455B Market-Cap Talk, and What’s Next (12.11.2025)

Palantir Stock Today (PLTR): Price, News and Analysis for November 18, 2025

Palantir Technologies’ share price is under pressure again today as investors wrestle with sky‑high valuations, growing “AI bubble” fears, and a wave of mixed institutional and analyst signals—even as the company’s underlying business continues to fire on all cylinders. FinancialContent+3StockAnalysis+3TradingView+3
18 November 2025
 ·  ·  ·  ·  · 
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle Stock Today (ORCL): OpenAI Deal Backlash, AI EHR Breakthrough and Annual Meeting Drive Volatility — November 18, 2025

Oracle Corporation’s stock remains in the spotlight on November 18, 2025, as investors digest a packed mix of headlines: a sharply repriced $300 billion OpenAI cloud deal, fresh concerns about debt-fueled AI spending, a new AI-powered electronic health record (EHR)
18 November 2025
 ·  ·  ·  ·  · 
Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Today, November 18, 2025: AMZN Slides as EU Cloud Probe, $15B Bond Sale and Analyst Downgrade Collide

Amazon stock (NASDAQ: AMZN) is under pressure today, with shares sliding in afternoon trading as investors digest a triple hit of headlines: a fresh EU cloud-computing probe, a rare analyst downgrade, and a multi‑billion‑dollar bond sale aimed at funding Amazon’s
18 November 2025
 ·  ·  ·  ·  · 
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock Today (Nov. 18, 2025): TSLA Hovers Around $400 as Nvidia Earnings and AI Valuation Jitters Hit the Market

Tesla stock (NASDAQ: TSLA) spent Tuesday trading around the psychologically important $400 level, slipping as broader tech and AI names sold off ahead of Nvidia’s closely watched earnings report and as high-profile voices questioned just how far the “AI trade”
18 November 2025
 ·  ·  ·  ·  · 
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Today, November 18, 2025: AI Supercomputer Win, Citi “King of the Hill” Call Clash With 5% Selloff

Published: November 18, 2025 – Market close Advanced Micro Devices (NASDAQ: AMD) shares pulled back sharply on Tuesday despite a fresh high‑profile supercomputer win in Europe and increasingly bullish commentary from Wall Street. By the closing bell, AMD stock had
18 November 2025
 ·  ·  ·  ·  · 
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk Stock Today (Nov 18, 2025): $199 Wegovy/Ozempic Intro Offer Drives Focus; Controlling Shareholder Sells ConvaTec Stake; NVO Edges Lower

Published November 18, 2025 Summary: Novo Nordisk (NYSE: NVO) remains in the spotlight after rolling out a U.S. self‑pay price cut for Wegovy and Ozempic—plus a two‑month $199 introductory offer for new patients—while its controlling shareholder Novo Holdings exited its
18 November 2025
 ·  ·  ·  ·  · 
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Stock Today, Nov 18, 2025: Shares Jump on Winrevair Phase 2 Win as Cidara Deal Builds Flu Portfolio

November 18, 2025 — Merck & Co. (NYSE: MRK) is trading higher today after the company reported new mid‑stage data for its cardiopulmonary medicine Winrevair (sotatercept‑csrk), fueling optimism about growth beyond Keytruda and adding momentum to last week’s acquisition of
18 November 2025
 ·  ·  ·  ·  · 
Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer Stock Today (Nov. 18, 2025): PFE steadies near $25 as Pfizer launches multi‑tranche bond sale to help fund Metsera deal

Summary Live PFE snapshot (intraday) New today: Pfizer sells debt to fund Metsera Pfizer began marketing a U.S. dollar investment‑grade bond expected to raise at least $5 billion, with the deal structured in as many as seven parts. Early discussions
18 November 2025
 ·  ·  ·  ·  ·  · 
1 … 48 49 50 51 52 … 424
Go toTop